Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01830725 · ClinicalTrials.gov registry record
Purine Metabolism Enzyme SNP to Uric Acid Production
A clinical trial, sponsored by Keesler Air Force Base Medical Center.
- Completed
- Registry status
- 100
- Enrollment target
NCT01830725 is a clinical trial that has completed, run by Keesler Air Force Base Medical Center. The registered enrollment target is 100 participants.
The verdict
NCT01830725 has completed, sponsored by Keesler Air Force Base Medical Center.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
Determine whether a relationship exists between polymorphisms of the genes XDH, HPRT1, and PRPS1 and gout, hyperuricemia, or the dose of xanthine oxidase (XO) inhibitors to reach a goal serum uric acid of less than 6 mg/dL. This study is observational in nature as no dose adjustment of XO inhibitors will be made by study investigators.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2012-12 |
| Est. Completion | 2016-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01830725
The ClinicalTrials.gov registry entry for NCT01830725 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Keesler Air Force Base Medical Center, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01830725 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01830725 about?
NCT01830725 is a clinical study titled "Purine Metabolism Enzyme SNP to Uric Acid Production". Determine whether a relationship exists between polymorphisms of the genes XDH, HPRT1, and PRPS1 and gout, hyperuricemia, or the dose of xanthine oxidase (XO) inhibitors to reach a goal serum uric acid of less than 6 mg/dL. This study is observational in nature as no dose adjustment of XO inhibitors...
What is the current status of trial NCT01830725?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2012-12. Estimated completion is 2016-06.
Who is sponsoring clinical trial NCT01830725?
This trial is sponsored by Keesler Air Force Base Medical Center, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.